Literature DB >> 23184462

Testing for differential item functioning within the EQ-5D.

David K Whynes1, Nikola Sprigg2, James Selby3, Eivind Berge4, Philip M Bath2.   

Abstract

We test for the presence of differential item functioning (DIF) in the EQ-5D health-related quality-of-life instrument, using data from a large clinical trial in acute stroke (ISRCTN 99414122). DIF occurs when subjects in different subsets of a sample respond differently to items in a measurement instrument, despite possessing the same latent traits. The data comprised 1462 patient records. We analyzed DIF specifically with respect to responses obtained from different geographical regions and responses obtained from proxies as opposed to the patients themselves. We mapped clinical outcome measures (scores from the modified Rankin Scale, the Barthel Index, and the Zung Depression scale) onto EQ-5D index scores and included dummy variables for proxy responses and for region of treatment (United Kingdom, Asia, rest of world). We predicted the level of problem severity reported on each of the EQ-5D's five constituent dimensions from the clinical measures and the dummy variables. For given clinical characteristics, proxies were more likely to report health problems than were the patients themselves, although the divergences were not sufficiently large to result in any significant difference in mean index scores between patient and proxy reports. However, the distributions of reported levels of problems for similar clinical states diverged significantly by region, and these translated into different index scores. The mean index score for UK responses was significantly higher than the mean index scores from Asia and the rest of the world.

Entities:  

Mesh:

Year:  2012        PMID: 23184462     DOI: 10.1177/0272989X12465016

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  14 in total

1.  Predictors of health-related quality of life in stroke patients after neurological inpatient rehabilitation: a prospective study.

Authors:  Mirjam Katona; Ralf Schmidt; Wilfried Schupp; Elmar Graessel
Journal:  Health Qual Life Outcomes       Date:  2015-05-14       Impact factor: 3.186

2.  Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2014-10-21       Impact factor: 79.321

3.  Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial.

Authors:  Kailash Krishnan; Polly Scutt; Lisa Woodhouse; Alessandro Adami; Jennifer L Becker; Lesley A Cala; Ana M Casado; Christopher Chen; Robert A Dineen; John Gommans; Panos Koumellis; Hanna Christensen; Ronan Collins; Anna Czlonkowska; Kennedy R Lees; George Ntaios; Serefnur Ozturk; Stephen J Phillips; Nikola Sprigg; Szabolcs Szatmari; Joanna M Wardlaw; Philip M Bath
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-02-04       Impact factor: 2.136

4.  Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.

Authors:  Philip M Bath; Polly Scutt; Daniel J Blackburn; Sandeep Ankolekar; Kailash Krishnan; Clive Ballard; Alistair Burns; Jonathan Mant; Peter Passmore; Stuart Pocock; John Reckless; Nikola Sprigg; Rob Stewart; Joanna M Wardlaw; Gary A Ford
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

5.  Developing a proxy version of the Adult social care outcome toolkit (ASCOT).

Authors:  Stacey Rand; James Caiels; Grace Collins; Julien Forder
Journal:  Health Qual Life Outcomes       Date:  2017-05-19       Impact factor: 3.186

6.  Paramedic Acute Stroke Treatment Assessment (PASTA): study protocol for a randomised controlled trial.

Authors:  Christopher I Price; Lisa Shaw; Peter Dodd; Catherine Exley; Darren Flynn; Richard Francis; Saiful Islam; Mehdi Javanbakht; Rachel Lakey; Joanne Lally; Graham McClelland; Peter McMeekin; Helen Rodgers; Helen Snooks; Louise Sutcliffe; Pippa Tyrell; Luke Vale; Alan Watkins; Gary A Ford
Journal:  Trials       Date:  2019-02-12       Impact factor: 2.279

7.  Does the correspondence between EQ-5D health state description and VAS score vary by medical condition?

Authors:  David K Whynes
Journal:  Health Qual Life Outcomes       Date:  2013-09-13       Impact factor: 3.186

8.  Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.

Authors:  Philip M W Bath; Aimee Houlton; Lisa Woodhouse; Nikola Sprigg; Joanna Wardlaw; Stuart Pocock
Journal:  Int J Stroke       Date:  2014-03-03       Impact factor: 5.266

9.  The economic burden of stroke care in England, Wales and Northern Ireland: Using a national stroke register to estimate and report patient-level health economic outcomes in stroke.

Authors:  Xiang-Ming Xu; Emma Vestesson; Lizz Paley; Anita Desikan; David Wonderling; Alex Hoffman; Charles DA Wolfe; Anthony G Rudd; Benjamin D Bray
Journal:  Eur Stroke J       Date:  2017-11-30

10.  Dependency and health utilities in stroke: Data to inform cost-effectiveness analyses.

Authors:  Myzoon Ali; Rachael MacIsaac; Terence J Quinn; Philip M Bath; David L Veenstra; Yaping Xu; Marian C Brady; Anita Patel; Kennedy R Lees
Journal:  Eur Stroke J       Date:  2017-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.